OROS JOHN J 4

What Happened John Oros, a director of Jefferson Capital, received grants of derivative securities on March 11, 2026. The filing reports two awards of 25,000 units each with per-share reported prices of $20.78 (25,000 × $20.78 = $519,500) and $34.78 (25,000 × $34.78 = $869,500), for a combined reported value of about $1,389,000. These are grants (transaction code A), i.e., awards of derivative securities (commonly stock options or similar), not open-market purchases or immediate sales.

Key Details

• Transaction date: 2026-03-11; Form 4 filed: 2026-03-13 (appears timely).
• Awards: 25,000 @ $20.78 (reported $519,500) and 25,000 @ $34.78 (reported $869,500); total 50,000 units, total ~$1.39M.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: Vesting is 1/3 of the shares annually, subject to continued service through each vest date (footnote F1).
• Transaction type: A (award/grant); securities are listed as "Derivative" (i.e., option-like instruments).

Context These grants are awards of derivative securities, which typically give the holder the right to acquire common shares under set terms and vesting; they are not the same as buying shares on the open market. The staged vesting (1/3 per year) means the awards become exercisable over time, contingent on continued service. Because this is a grant, it signals compensation/retention rather than an immediate buy or sell of stock. The filing was submitted within the standard reporting window and therefore does not appear to be late.